About PhysIOL
PhysIOL is a Healthcare company based in Liege (Belgium) founded in 1986, and was acquired by Beaver-Visitec International in December 2018. It operates as an innovative intraocular lenses for cataract surgery are manufactured. The company was acqui-hired. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is BEAVER-VISITEC INTERNATIONAL SALES LTD. Its competitors include RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Physiol offers research and develops optical solutions for cataract surgery. They develop and manufacture intraocular lenses which include the process polymer chemistry to sterilization processes, including modeling and risk-control associated with implantable materials. Their products include Trifocal and trifocal toric IOLs, Monofocal preloaded and non-preloaded IOLs, Monofocal hydrophobic glistening-free preloaded and non-preloaded IOLs, Monofocal toric IOLs. Currently, they provide their services in 60 countries.
- Headquarters Liege, Belgium
- Stage Acquired
- SectorsHealthcare
- Website physiol.eu
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Beaver-Visitec International (Dec 2018)
- Legal Name Beaver-Visitec International Sales Ltd
- InvestorsBeaver-Visitec International
& 1 more
- Acquired byBeaver-Visitec International
(Dec 2018)
Apps and channels of PhysIOL
its YouTube channel BVI Medical has 1.43K subscribers and 30 videos.
Videos from PhysIOL
The most watched videos on PhysIOL's YouTube channel, BVI Medical (1.43K subscribers). Click a video to play it here.
More on BVI Medical.
Funding Insights of PhysIOL
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of PhysIOL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | – | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in PhysIOL
PhysIOL has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Beaver-Visitec International and TA Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by private equity firm TA. | – | ta.com | Boston, United States | |
Ophthalmic products and surgical supplies are provided globally. | 1986 | bvimedical.com | Waltham, United States |
Investor details for PhysIOL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PhysIOL
3 dated milestones of PhysIOL across 32 years, from founding to its latest funding, stage changes and deals.
- Founded PhysIOL is founded.
- Funding First funding round.
- Exit Acquired by Beaver-Visitec International.
Competitors of PhysIOL
PhysIOL has 7 listed competitors in our database, 6 of them funded. They include RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rxsight.com | 1997 | Aliso Viejo, United States | $198.73M | 263 | Adjustable intraocular lens technology is developed using UV-sensitive macromers. | |
| atiavision.com | 2012 | Campbell, United States | $67M | – | A presbyopia-correcting intraocular lens is developed for cataract patients. | |
| staar.com | 1982 | Monrovia, United States | – | 1,115 | Manufacturer of implantable lenses for the eye with companion delivery systems | |
| nayaminnovations.com | 2012 | Pune, India | $3.26M | 248 | Artificial intraocular lenses for cataract treatment are developed. | |
| wavetecvision.com | 1997 | Aliso Viejo, United States | $85.16M | 64 | Intraoperative guidance for IOL alignment in cataract surgery is offered. | |
| wx-visionpro.com | 2010 | Wuxi, China | $12.58M | – | Manufacturer of intraocular lenses and related products | |
| visiogen.com | 2001 | Irvine, United States | $40M | – | Dual optic intraocular lenses for cataract treatment were developed. |
Detailed competitors of PhysIOL
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PhysIOL
Websites that share an audience with PhysIOL (physiol.eu).
Websites whose visitors overlap most with PhysIOL. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medicalmix.com | 100% | 6.4K | #3,023,205 | View details | |
| ziemergroup.com | 86% | 4.6K | #3,659,331 | View details | |
 historiadelamedicina.wordpress.com | historiadelamedicina.wordpress.com | 84% | – | #2,569,925 | – |
ngha.med.sa | ngha.med.sa | 84% | – | #93,361 | – |
gatinel.com | gatinel.com | 53% | – | #694,026 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for PhysIOL
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
10 companies that operate in the same segment as PhysIOL (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Physiol
Complete news archive for PhysIOL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PhysIOL
PhysIOL was founded in 1986 and raised its 1st funding round 29 years after it was founded.
PhysIOL is headquartered in Liege, Belgium. It is registered at Liege, Liege, Belgium.
Physiol offers research and develops optical solutions for cataract surgery. They develop and manufacture intraocular lenses which include the process polymer chemistry to sterilization processes, including modeling and risk-control associated with implantable materials. Their products include Trifocal and trifocal toric IOLs, Monofocal preloaded and non-preloaded IOLs, Monofocal hydrophobic glistening-free preloaded and non-preloaded IOLs, Monofocal toric IOLs. Currently, they provide their services in 60 countries.
PhysIOL's top competitors include RxSight, Nayam Innovations and Atia Vision.
PhysIOL has 2 investors. Key investors include Beaver-Visitec International, and TA Associates.
PhysIOL operates through Beaver-Visitec International Sales Ltd.
Yes. PhysIOL was acquired by Beaver-Visitec International in December 2018.